clarithromycin has been researched along with Neoplasms in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Bahl, A; Bai, J; Campen, MJ; Chai, H; Chen, C; Chen, J; Chen, X; Cheng, L; Cheng, W; Dong, Q; Easton, J; Engberg, E; Fadladdin, YAJ; Franco, PM; Gao, J; Giri, AR; Goodarzi, Z; Graves, SA; Guo, Y; Holroyd-Leduc, J; Hu, Z; Huang, IC; Hudson, MM; Ji, X; Jiang, J; Johnson, S; Kaur, N; Koivusalo, SB; Kulmala, J; Lan, Q; Leng, S; Li, Q; Li, Y; Li, Z; Liang, R; Liu, F; Liu, Y; Lowman, PE; Ma, X; Menda, Y; Mielke, N; Mulder, H; Neale, G; Ness, KK; Niaz, S; Niu, Q; Pang, H; Park, EA; Plyler, E; Qin, N; Qin, X; Qiu, H; Ren, D; Ren, J; Roach, M; Robison, LL; Roine, RP; Rothman, N; Rottman Pietrzak, KA; Sahrakorpi, N; Sanghavi, DK; Santos, C; Shallom, SJ; Song, N; Spotswood, N; Stach-Lempinen, B; Subota, A; Sun, X; Tammelin, TH; Tang, J; Walker, E; Wang, M; Wang, Z; Xie, J; Xu, J; Xue, J; Xue, M; Yang, S; Yang, Y; Yarrarapu, SNS; Yasui, Y; Yu, H; Yu, W; Zelazny, AM; Zhang, H; Zhang, J; Zhang, X; Zheng, Y; Zhu, D | 1 |
| Bessudo, A; Esseltine, DL; Gupta, N; Hanley, MJ; Ke, A; Liu, G; Nemunaitis, J; O'Neil, BH; Patel, C; Rasco, DW; Rowland Yeo, K; Sharma, S; Venkatakrishnan, K; Wang, B; Xia, C; Zhang, X | 1 |
| Adderson, EE; Apiwattankul, N; Flynn, PM; Hayden, RT | 1 |
| Nishi, Y; Sakamoto, Y; Sakata, N; Shibasaki, M; Shimono, N | 1 |
| Inoue, K; Kimura, K; Mizukoshi, T; Nishi, Y; Sakamoto, Y; Sakata, K; Shibazaki, M | 1 |
| Azuma, A; Hibino, S; Kokubo, Y; Kudo, S; Matsuda, K; Ono, Y; Shibuya, N; Shinoda, K; Takeichi, A; Zou, DT | 1 |
| Ivanov, VP; Krest'ianova, IN; Sazykin, IuO | 1 |
| Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
| Gooch, G; Ho, D; Rolston, K | 1 |
3 review(s) available for clarithromycin and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Topics: Adult; Aging; Aluminum; Alzheimer Disease; Animals; Anti-Bacterial Agents; Artemisia annua; Body Mass Index; Brain; Canada; Cancer Survivors; Cardiovascular Diseases; Child; Clarithromycin; Cohort Studies; Cricetinae; Critical Care; Cross-Sectional Studies; Deferoxamine; Dementia; Depression; Diabetes Mellitus, Type 2; Diabetes, Gestational; DNA Methylation; Drug Resistance, Bacterial; Endothelial Cells; Epigenesis, Genetic; Exercise; Female; Ferroptosis; Garlic; Genetic Loci; Genome-Wide Association Study; Humans; Intensive Care Units; Iron; Iron Chelating Agents; Ketamine; Kidney; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Neoplasms; Neuroendocrine Tumors; Neurons; Nigella sativa; Obesity; Overweight; Oxidative Stress; Plant Extracts; Praziquantel; Pregnancy; Quality of Life; Radiometry; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Research Design; Retrospective Studies; RNA, Ribosomal, 23S; Schistosoma mansoni; Schistosomiasis; Schistosomiasis mansoni; Survivors; Vehicle Emissions | 2022 |
Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer.
Topics: Adolescent; Amikacin; Anti-Infective Agents; Catheter-Related Infections; Child; Child, Preschool; Clarithromycin; Debridement; Female; Humans; Immunocompromised Host; Infant; Lung Diseases; Male; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Neoplasms; Retrospective Studies | 2015 |
1 trial(s) available for clarithromycin and Neoplasms
| Article | Year |
|---|---|
Effects of Strong CYP3A Inhibition and Induction on the Pharmacokinetics of Ixazomib, an Oral Proteasome Inhibitor: Results of Drug-Drug Interaction Studies in Patients With Advanced Solid Tumors or Lymphoma and a Physiologically Based Pharmacokinetic Ana
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Boron Compounds; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Glycine; Humans; Ketoconazole; Male; Middle Aged; Models, Biological; Neoplasms; Proteasome Inhibitors; Rifampin | 2018 |
6 other study(ies) available for clarithromycin and Neoplasms
| Article | Year |
|---|---|
[Influence of clarithromycin and azithromycin on cell cycle of neoplasms].
Topics: Anti-Bacterial Agents; Azithromycin; Cell Cycle; Clarithromycin; Depression, Chemical; Dose-Response Relationship, Drug; Humans; Neoplasms; Tumor Cells, Cultured | 2003 |
[Effect of macrolide antibiotics on adhesion by cancer cells].
Topics: Anti-Bacterial Agents; Azithromycin; Biocompatible Materials; Cell Adhesion; Clarithromycin; Collagen; Drug Combinations; Flow Cytometry; Humans; Laminin; Neoplasms; Proteoglycans; Tumor Cells, Cultured | 2000 |
[Effect of clarithromycin on adhesion and infiltration of cancer cells].
Topics: Animals; Anti-Bacterial Agents; Cell Adhesion; Clarithromycin; Humans; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasms; Tumor Cells, Cultured | 2000 |
[Clarithromycin and tumor chemotherapy].
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Clarithromycin; Humans; Neoplasms | 2000 |
Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.
Topics: Anti-Bacterial Agents; Clarithromycin; Clindamycin; Erythromycin; Gram-Positive Bacteria; Humans; Macrolides; Microbial Sensitivity Tests; Neoplasms; Roxithromycin; Sepsis | 1990 |
In-vitro activity of clarithromycin (A-56268; TE-031) against gram-positive bacteria.
Topics: Bacterial Infections; Clarithromycin; Erythromycin; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Neoplasms | 1989 |